Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update

November 10, 2022

https://www.globenewswire.com/news-release/2022/11/10/2553272/0/en/Femasys-Inc-Announces-Financial-Results-for-the-Third-Quarter-Ended-September-30-2022-and-Provides-Corporate-Update.html

–FemaSeed® de novo trial enrollment accelerates with strategic trial design update to focus on male factor infertility–

—Company remains on track to file an Investigational Device Exemption (IDE) for a pivotal trial to support a Pre-Market Authorization (PMA) for FemBloc® in Q1 2023–

Read more at globenewswire.com

Related news for (FEMY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.